CATEGORY D |
EFFECTS |
CATEGORY X |
EFFECTS |
Angiotensin-converting enzyme inhibitors |
Unsafe after the first trimester; renal failure and death in neonate |
Measles, mumps, rubella, varicella live-attenuated vaccines |
Congenital viral syndromes |
Anticholinergic drugs |
Neonatal meconium ileus |
Danazol |
Ambiguous genitalia |
Antithyroid drugs |
Neonatal goiter and hypothyroidism, aplasia cutis (methimazole) |
Warfarin |
Embryopathy: hypoplastic nose, epiphyseal stippling, optic atrophy, microcephaly, and growth restriction |
Carbamazepine |
Neural tube defects (NTDs) |
Diethylstilbestrol |
Vaginal adenosis and clear cell carcinoma in offspring |
Lithium |
Ebstein’s anomaly |
Vitamin A |
Spontaneous abortions and fetal malformations |
Nonsteroidal anti-inflammatory drugs |
Constriction of the ductus arteriosus in third trimester |
Isotretinoin |
Isotretinoin syndrome |
Phenytoin |
Fetal hydantoin syndrome |
Triazolam |
Cleft palate |
Psychoactive drugs |
Fetal withdrawal syndrome |
Lovastatin |
Bone malformation |
Tetracycline |
Tooth discoloration, bone malformation |
Thalidomide |
Limb-shortening defects |
Valproic acid |
NTDs |
Ribavirin |
Embryocidal |
|
|
Lead, methyl mercury, polychlorinated and polybrominated biphenyls, organic solvents |
Assorted mental, physical, and metabolic effects |
|
|
Ionizing radiation |
Miscarriage |